Share on StockTwits

Shares of LifePoint Hospitals (NASDAQ:LPNT) reached a new 52-week high on Friday , AnalystRatings.Net reports. The stock traded as high as $76.50 and last traded at $74.37, with a volume of 207,610 shares traded. The stock had previously closed at $74.46.

A number of research firms have recently commented on LPNT. Analysts at Citigroup Inc. reiterated a “buy” rating on shares of LifePoint Hospitals in a research note on Monday, July 28th. They now have a $81.00 price target on the stock, up previously from $64.00. Separately, analysts at JPMorgan Chase & Co. raised their price target on shares of LifePoint Hospitals from $65.00 to $76.00 in a research note on Monday, July 28th. Finally, analysts at Barclays raised their price target on shares of LifePoint Hospitals from $59.00 to $69.00 in a research note on Monday, July 28th. They now have an “underweight” rating on the stock. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and five have given a buy rating to the company. LifePoint Hospitals has a consensus rating of “Hold” and an average price target of $70.21.

The stock has a 50-day moving average of $68.64 and a 200-day moving average of $59.58. The company has a market cap of $3.364 billion and a P/E ratio of 24.50.

LifePoint Hospitals (NASDAQ:LPNT) last released its earnings data on Friday, July 25th. The company reported $0.84 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.55 by $0.29. The company had revenue of $1.05 billion for the quarter, compared to the consensus estimate of $1.01 billion. During the same quarter last year, the company posted $0.65 earnings per share. LifePoint Hospitals’s revenue was up 15.4% compared to the same quarter last year. Analysts expect that LifePoint Hospitals will post $3.09 EPS for the current fiscal year.

LifePoint Hospitals, Inc (NASDAQ:LPNT), through its subsidiaries, operates general acute care hospitals in non-urban communities in the United States.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.